BPC 157 Peptide Therapy Regenerative Medicine Dr. Henry Sobo, MD Read this paper describing a large case series of patients with mast cell activation syndrome (MCAS) and comorbidities, whose MCAS associated symptoms improved significantly on GLP1 agonists. To summarize: 47 Mast Cells: MCAS, Genetics, and Solutions Most people diagnosed with MCAS didn't develop it overnight. Their mast cells were dysregulated long before symptoms appeared. Early life exposures, such as environmental toxins, infections, and even implants, can alter how mast BPC 157 What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B